C62 -Malignant neoplasm of testis
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C62 – N =11,980
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1982 | 26.4% | 21.8% | 14.7% | 0% | 37.1% | 197 |
1983 | 43% | 21.3% | 16.1% | 0% | 19.6% | 230 |
1984 | 41.3% | 18.9% | 13.3% | 0% | 26.5% | 196 |
1985 | 39.1% | 24.5% | 12.9% | 0% | 23.6% | 233 |
1986 | 33.3% | 25.7% | 12.7% | 0% | 28.3% | 237 |
1987 | 35% | 24.6% | 15.4% | 0% | 25% | 240 |
1988 | 39% | 25% | 13.3% | 0% | 22.7% | 264 |
1989 | 39.5% | 23.6% | 11.2% | 0% | 25.7% | 276 |
1990 | 40.4% | 22.6% | 13.1% | 0% | 23.9% | 297 |
1991 | 38.4% | 25.1% | 13.7% | 0% | 22.8% | 307 |
1992 | 42.2% | 24.2% | 15.2% | 0% | 18.3% | 289 |
1993 | 43.5% | 22.7% | 13.9% | 0% | 19.9% | 331 |
1994 | 50.9% | 20.4% | 13.3% | 0% | 15.4% | 338 |
1995 | 53% | 19.3% | 14.3% | 0% | 13.4% | 321 |
1996 | 50.4% | 21.7% | 13.8% | 0% | 14.1% | 355 |
1997 | 55.7% | 17.9% | 14.2% | 0% | 12.2% | 402 |
1998 | 52.9% | 19.8% | 13.8% | 0% | 13.5% | 348 |
1999 | 58.2% | 17.4% | 11.3% | 0% | 13.2% | 380 |
2000 | 57.7% | 21.8% | 10.6% | 0% | 9.9% | 395 |
2001 | 60.2% | 17.9% | 14% | 0% | 7.9% | 379 |
2002 | 61.7% | 13.7% | 17.8% | 0% | 6.9% | 394 |
2003 | 56.8% | 16.9% | 18.7% | 0% | 7.5% | 438 |
2004 | 60.3% | 17.7% | 15.6% | 0% | 6.5% | 418 |
2005 | 60.8% | 15% | 12.8% | 0% | 11.3% | 452 |
2006 | 68.6% | 10.6% | 15% | 0% | 5.8% | 452 |
2007 | 65.6% | 15.7% | 14.3% | 0% | 4.5% | 491 |
2008 | 65.9% | 16.3% | 14.1% | 0% | 3.7% | 455 |
2009 | 65.2% | 20.4% | 11.1% | 0% | 3.2% | 494 |
2010 | 65.9% | 14.5% | 14.7% | 0% | 4.9% | 490 |
2011 | 62.1% | 12.3% | 8.7% | 0% | 16.8% | 470 |
2012 | 60.6% | 10.3% | 6.5% | 0% | 22.6% | 465 |
2013 | 65.8% | 10.5% | 9.7% | 0% | 13.9% | 474 |
2014 | 72.2% | 13.1% | 9.3% | 0% | 5.3% | 472 |